摘要
目的:体外评价可利霉素对口腔鳞状细胞癌的抗肿瘤活性。方法:梯度浓度可利霉素分别处理口腔鳞状细胞癌细胞(HN6/HB96细胞系),采用CCK-8试剂盒检测细胞增殖,绘制生长曲线;采用划痕实验分析细胞迁移能力;采用平板克隆形成实验分析细胞克隆形成能力;采用流式细胞术分析细胞周期和细胞凋亡。采用SPSS 18.0软件包对数据进行统计学分析。结果:可利霉素浓度依赖性抑制HN6/HB96的体外增殖,随着药物浓度增加,细胞迁移和克隆形成能力显著下降(P<0.05);可利霉素使处理过的口腔鳞状细胞癌细胞G1期比例显著升高,S期和G2/M期比例显著下降,细胞周期阻滞于G1期(P<0.001)。可利霉素诱导口腔鳞状细胞癌细胞凋亡,随着药物浓度增加,细胞凋亡率显著上升(P<0.01)。结论:可利霉素体外抑制口腔鳞状细胞癌细胞的生物学活性,为可利霉素用于口腔鳞状细胞癌的治疗提供了实验依据。
PURPOSE:As a new macrolide antibiotic with independent intellectual property rights of China,carrimycin not only has good antibacterial effect on a variety of bacteria,but also has the function of regulating cell physiology and proliferation.The aim of this study was to investigate the anti-tumor effects of carrimycin on the biological activity of oral squamous cell carcinoma(OSCC)cells in vitro.METHODS:OSCC cells(HN6/HB96 cell lines)were treated with gradient concentration of carrimycin.Cell proliferation was detected using CCK-8 kit,based on which cell growth curve was drawn.Cell migration ability was analyzed by wound-healing assay.Cell clone formation ability was analyzed by clone formation assay.Cell cycle and apoptosis were analyzed by flow cytometry.SPSS18.0 software package was used for statistical analysis.RESULTS:Carrimycin concentration-dependently inhibited cellular proliferation of OSCC cells of HN6 and HB96 in vitro.With the increase of drug concentration,cell migration and clonal formation ability significantly decreased(P<0.05).The G1 phase ratio of OSCC cells treated with carrimycin significantly increased,while the S and G2/M phase ratio decreased,indicating that the cell cycle was arrested in G1 phase(P<0.001).The apoptosis rate of OSCC cells was significantly increased with the increase of drug concentration(P<0.01).CONCLUSIONS:The activity of OSCC cells can be effectively inhibited by carrimycin,which provides experimental evidence for the application of carrimycin in OSCC.
作者
梁思源
赵铜超
周知航
琚梧桐
刘莹
张志愿
钟来平
LIANG Siyuan;ZHAO Tong-chao;ZHOU Zhi-hang;JU Wu-tong;LIU Ying;ZHANG Zhi-yuan;ZHONG Lai-ping(Department of Oromaxillofacial Head and Neck Oncology,Shanghai Ninth People's Hospital,College of Stomatology,Shanghai Jiao Tong University School of Medicine,National Clinical Research Center for Oral Diseases,Shanghai Key Laboratory of Stomatology&Shcuighm Reasearch Institute of Stomatology,Shanghai 200011,China)
出处
《中国口腔颌面外科杂志》
CAS
2020年第4期308-313,共6页
China Journal of Oral and Maxillofacial Surgery
基金
上海交通大学医学院附属第九人民医院临床研究型MDT项目(201916)
上海交通大学医学院双百人计划(20191915)。
关键词
可利霉素
抗生素
口腔鳞状细胞癌
Carrimycin
Antibiotics
Oral squamous cell carcinoma